260 related articles for article (PubMed ID: 38016582)
41. Common and Challenging Behaviors Among Individuals on Long-term Opioid Therapy.
Young SR; Azari S; Becker WC; Edelman EJ; Liebschutz JM; Roy P; Starrels JL; Merlin JS
J Addict Med; 2020; 14(4):305-310. PubMed ID: 31855919
[TBL] [Abstract][Full Text] [Related]
42. Associations between naloxone prescribing and opioid overdose among patients with acute and chronic pain conditions.
Qeadan F; Madden EF
Addiction; 2022 Feb; 117(2):457-471. PubMed ID: 34286895
[TBL] [Abstract][Full Text] [Related]
43. Do Formulation and Dose of Long-Term Opioid Therapy Contribute to Risk of Adverse Events among Older Adults?
Salkar M; Ramachandran S; Bentley JP; Eriator I; McGwin G; Twyner CC; Yang Y
J Gen Intern Med; 2022 Feb; 37(2):367-374. PubMed ID: 34258726
[TBL] [Abstract][Full Text] [Related]
44. Opioid Use Disorder Among Ohio's Medicaid Population: Prevalence Estimates From 19 Counties Using a Multiplier Method.
Doogan NJ; Mack A; Wang J; Crane D; Jackson R; Applegate M; Villani J; Chandler R; Barocas JA
Am J Epidemiol; 2022 Nov; 191(12):2098-2108. PubMed ID: 36004683
[TBL] [Abstract][Full Text] [Related]
45. Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2021 Apr; 221():108555. PubMed ID: 33596496
[TBL] [Abstract][Full Text] [Related]
46. Examination of methadone involved overdoses during the COVID-19 pandemic.
Kaufman DE; Kennalley AL; McCall KL; Piper BJ
Forensic Sci Int; 2023 Mar; 344():111579. PubMed ID: 36739850
[TBL] [Abstract][Full Text] [Related]
47. Opioid Use Disorder and Overdose in the First Year Postpartum: A Rapid Scoping Review and Implications for Future Research.
Frankeberger J; Jarlenski M; Krans EE; Coulter RWS; Mair C
Matern Child Health J; 2023 Jul; 27(7):1140-1155. PubMed ID: 36840785
[TBL] [Abstract][Full Text] [Related]
48. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
[TBL] [Abstract][Full Text] [Related]
49. Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study.
Tipping AD; Nowels M; Moore C; Samples H; Crystal S; Olfson M; Williams AR; Heaps-Woodruff J
J Subst Use Addict Treat; 2024 Feb; 157():209218. PubMed ID: 37984564
[TBL] [Abstract][Full Text] [Related]
50. Incidence of Postoperative Opioid Overdose and New Diagnosis of Opioid Use Disorder Among US Veterans.
Siglin J; Sorkin JD; Namiranian K
Am J Addict; 2020 Jul; 29(4):295-304. PubMed ID: 32202000
[TBL] [Abstract][Full Text] [Related]
51. Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators.
O'Grady MA; Elkington KS; Robson G; Achebe IY; Williams AR; Cohall AT; Cohall R; Christofferson M; Garcia A; Ramsey KS; Lincourt P; Tross S
Subst Abuse Treat Prev Policy; 2024 Jan; 19(1):12. PubMed ID: 38287329
[TBL] [Abstract][Full Text] [Related]
52. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose.
Karmali RN; Ray GT; Rubinstein AL; Sterling SA; Weisner CM; Campbell CI
Drug Alcohol Depend; 2020 Apr; 209():107923. PubMed ID: 32126455
[TBL] [Abstract][Full Text] [Related]
53. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.
Alexander K; Pogorzelska-Maziarz M; Gerolamo A; Hassen N; Kelly EL; Rising KL
Subst Abuse Treat Prev Policy; 2021 Aug; 16(1):60. PubMed ID: 34372900
[TBL] [Abstract][Full Text] [Related]
54. Impact of the COVID-19 pandemic on opioid overdose and other adverse events in the USA and Canada: a systematic review.
Simha S; Ahmed Y; Brummett CM; Waljee JF; Englesbe MJ; Bicket MC
Reg Anesth Pain Med; 2023 Jan; 48(1):37-43. PubMed ID: 36202619
[TBL] [Abstract][Full Text] [Related]
55. Stimulant use and opioid-related harm in patients on long-term opioids for chronic pain.
Appa A; McMahan VM; Long K; Shade SB; Coffin PO
Drug Alcohol Depend; 2024 Mar; 256():111065. PubMed ID: 38245963
[TBL] [Abstract][Full Text] [Related]
56. Variation in Clinical Characteristics and Longitudinal Outcomes in Individuals with Opioid Use Disorder Diagnosis Codes.
Powell VD; Macleod C; Sussman J; Lin LA; Bohnert ASB; Lagisetty P
J Gen Intern Med; 2023 Feb; 38(3):699-706. PubMed ID: 35819683
[TBL] [Abstract][Full Text] [Related]
57. Arguments for and Against a New Diagnostic Entity for Patients With Chronic Pain on Long-Term Opioid Therapy for Whom Harms Outweigh Benefits.
Edmond SN; Snow JL; Pomeranz J; Van Cleve R; Becker WC
J Pain; 2022 Jun; 23(6):958-966. PubMed ID: 34974174
[TBL] [Abstract][Full Text] [Related]
58. A Preliminary Study of Stress, Mental Health, and Pain Related to the COVID-19 Pandemic and Odds of Persistent Prescription Opioid Use.
Scherrer JF; Miller-Matero LR; Sullivan MD; Chrusciel T; Salas J; Davidson W; Zabel C; Wilson L; Lustman P; Ahmedani B
J Gen Intern Med; 2023 Mar; 38(4):1016-1023. PubMed ID: 36385413
[TBL] [Abstract][Full Text] [Related]
59. Associations between elevated depressive symptoms and substance use, prescription opioid misuse, overdose history, pain, and general health among community pharmacy patients prescribed opioids.
Brown JL; Cochran G; Bryan MA; Charron E; Winhusen TJ
Subst Abus; 2022; 43(1):1110-1115. PubMed ID: 35499399
[No Abstract] [Full Text] [Related]
60. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
